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ABSTRACT 25 
Objective: To further explore deiodinase iodothyronine type-2 (DIO2) as a therapeutic 26 
target in osteoarthritis by studying the effects of forced mechanical loading on in vivo 27 
joint cartilage tissue homeostasis and the modulating effect herein of Dio2 deficiency.  28 
Methods: Wild-type and C57BL/6-Dio2 -/- -mice were subjected to a forced running 29 
regime for one hour per day for three weeks. Severity of osteoarthritis was assessed by 30 
histological scoring for cartilage damage and synovitis. Genome wide gene expression 31 
was determined in knee-cartilage by microarray analysis (Illumina MouseWG-6 v2). 32 
STRING-db analyses were applied to determine enrichment for specific pathways and to 33 
visualize protein-protein interactions. 34 
Results: In total, 158 probes representing 147 unique genes showed significantly 35 
differential expression with a fold-change ≥ 1.5 upon forced exercise. Among these are 36 
genes known for their association with OA (e.g. Mef2c, Egfr, Ctgf, Prg4 and Ctnnb1), 37 
supporting the use of forced running as an OA-model in mice. Dio2-deficient mice 38 
showed significantly less cartilage damage and signs of synovitis. Gene expression 39 
response upon exercise between wild-type and knockout-mice was significantly different 40 
for 29 genes.  41 
Conclusion: Mice subjected to a running regime have significant increased cartilage 42 
damage and synovitis scores. Lack of Dio2 protected against cartilage damage in this 43 
model and was reflected in a specific gene expression profile, and either mark a favorable 44 
effect in the Dio2-knockout (e.g. Gnas) or an unfavorable effect in wild-type cartilage 45 
homeostasis (e.g. Hmbg2 and Calr). These data further support DIO2 activity as a 46 
therapeutic target in OA. 47 
48 
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INTRODUCTION 48 
Osteoarthritis (OA) is a prevalent, complex, chronic and disabling disease of articular 49 
joints, characterized by progressive destruction of joint cartilage, remodeling of the 50 
subchondral bone, formation of osteophytes and synovitis [1, 2]. It causes pain and 51 
disability to an increasing proportion of the population and is associated with the obesity 52 
pandemic, aging of the population and not in the least by improved survival of patients 53 
with cardiovascular or oncological health problems. All together this imposes a large and 54 
growing social and economic burden [3, 4]. The development of novel therapeutic 55 
approaches is therefore urgently needed and should be based on insights into the 56 
underlying disease mechanisms [5-7]. Several genetic studies identified robust signals for 57 
OA susceptibility [8-13], that suggest specific genes, involved in cartilage development 58 
and growth, to play a key role in the OA disease process [14, 15]. Notable example of 59 
such OA susceptibility alleles, are the C-variant of the rs225014 single nucleotide 60 
polymorphism (SNP) located in the coding region of the deiodinase iodothyronine type-2 61 
(D2) gene (DIO2) [8, 16] and the rs945006 SNP in the deiodinase iodothyronine type-3 62 
(D3) gene (DIO3), another deiodinase with a counter regulatory function for DIO2 [16].  63 
For together, D2 and D3 primarily regulate the bio-availability of intracellular thyroid 64 
hormone in specific tissues such as the growth plate, but not systemically. The deiodinase 65 
type 2 protein (D2) catalyzes the conversion of intracellular inactive thyroxine (T4) to 66 
active thyroid hormone (T3). During skeletal development, this conversion plays a 67 
critical role in the process of endochondral bone formation by facilitating terminal 68 
maturation of hypertrophic chondrocytes subsequently leading to breakdown of the 69 
cartilage matrix and replacement by bone. This process is essential in skeletal 70 
  4 
development and growth but loss of the chondrocyte’s maturational arrested 71 
characteristics is considered deleterious for postnatal articular cartilage.[17, 18]  DIO2 72 
mRNA and D2 protein levels are highly upregulated in human osteoarthritic cartilage as 73 
compared to healthy cartilage [19-21], suggesting that in disease DIO2 contributes to the 74 
loss of the highly specialized maturational arrested state of articular chondrocytes [17]. 75 
Cartilage-specific over-expression of human DIO2 in rats was associated with increased 76 
damage to the articular cartilage in a surgical OA model. However, this was without clear 77 
evidence that hypertrophy of chondrocytes plays an essential role and rather pointing 78 
towards increased tissue destructive enzyme activity and enhanced expression of IL-1 79 
target genes [22]. Upregulation of DIO2 expression in a human in vitro model resulted in 80 
a marked reduction of the capacity of chondrocytes to deposit ECM components, 81 
including type II and type X collagen, while inducing OA-specific markers of cartilage 82 
matrix degeneration and mineralization [18]. In contrast, pharmalogical inhibition of 83 
DIO2 increased the expression of collagens and aggrecan without clear effect on 84 
hypertrophy or tissue destructive enzymes. These accumulating data suggest that D2 85 
inhibition and/or modulation may become a therapeutic target, but the in vivo impact of 86 
D2 loss of function in joint biology and disease remains largely unknown in particular at 87 
the molecular level.  88 
In this study, we set out to study the molecular network of Dio2 in the healthy and 89 
challenged joint. We performed genome wide expression analyses in aging wild-type and 90 
Dio2-/- mice, including groups exposed to a moderately strenuous running regime. Our 91 
results indicate that Dio2 is effectively involved in specific gene networks that can be 92 
associated with osteoarthritis and provide further insights into the complex molecular 93 
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interactions involved in healthy and diseases articular cartilage. 94 
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MATERIALS AND METHODS 95 
Animal experiments 96 
Dio2-/- mice were a kind gift of Dr. V. Galton (Dartmouth Medical School, NH, 97 
USA)[23] and were backcrossed onto the C57Bl/6 background. All experiments were 98 
approved by the Ethics Committee for Animal Research (KU Leuven, Belgium). 99 
Four to 6 months old male Dio2-/- (n=22) and wild-type mice (n=30) ran for 3 weeks 1 100 
hour/day, 5 days/week, at a speed of 11 m/min and with an inclination of 5°.  For 101 
additional details, see the Online Methods. 102 
 103 
Histological assessment of osteoarthritis 104 
Right knees were fixed overnight at 4°C in 2% formaldehyde, decalcified for 3 weeks in 105 
0.5M EDTA pH 7.5 and embedded in paraffin. Severity of disease was determined by 106 
histological scores on hematoxylin/eosin or Safranin O stained sections (5µm) throughout 107 
the knee (5 sections at 100µm distance). For additional details on histological assessment 108 
and statistical analyses, see the Online Methods. 109 
 110 
RNA isolation 111 
Snap frozen cartilage of the left knees was powderized using a Retsch Mixer Mill 200 112 
under cryogenic conditions. RNA was isolated and washed using the RNeasy mini kit 113 
(Qiagen, Venlo, The Netherlands) according to the manufacturer’s protocol. RNA quality 114 
was assessed using a Biocore lab-on-a-chip and quantity was assessed using a Nanodrop 115 
spectrophotometer. For additional details, see the Online Methods. 116 
 117 
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Microarray analysis 118 
Complementary DNA synthesis, amplification, biotin labeling and hybridization onto the 119 
microarrays was performed using the Ambion TotalPrep-96 RNA amplification kit (Life 120 
Technologies, Bleiswijk, The Netherlands) according to manufacturer’s protocol. After 121 
hybridization on Illumina MouseWG-6 v2 BeadChip microarrays (Illumina, Eindhoven, 122 
The Netherlands) the slides were scanned with the Illumina Beadscanner 500GX. For 123 
additional details on microarray handling and data analyses, see the Online Methods. 124 
 125 
Pathway analysis and protein-protein interaction networks 126 
Gene enrichment among the genes with significant differential expression was performed 127 
with STRING (Search Tool for the Retrieval of Interacting Genes/Proteins 9.1) [24]. 128 
Pathways with a P-value ≤ 0.05 after FDR correction were considered significant. 129 
Enrichment in protein-protein interactions was also analyzed using the STRING database. 130 
For additional details, see the Online Methods 131 
 132 
Quantitative RT-PCR assays (validation) 133 
Validation of the microarray results was performed by quantitative real-time PCR. 500 ng 134 
of total RNA was processed with the First Strand cDNA Synthesis Kit according to the 135 
manufacturer’s protocol (Roche Applied Science, Almere, The Netherlands) upon which 136 
cDNA was diluted 5 times. RT-qPCR measurements were performed on the Roche 137 
Lightcycler 480 II, using Fast Start Sybr Green Master reaction mix according to the 138 
manufacturer’s protocol (Roche Applied Science). For additional details, see the Online 139 
Methods. 140 
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RESULTS 141 
Reduced severity of OA after forced running in Dio2-/- mice 142 
To study the role of Dio2 in joint homeostasis, Dio2-/- and wild-type mice were studied in 143 
a forced-exercise setup and compared to non-running mice (Figure 1). No striking 144 
developmental skeletal phenotype appears present in the Dio2-/- mice [25] and our 145 
observations in our mouse colony are in agreement with these findings. Wild-type and 146 
Dio2-/- mice displayed a similar running behavior. As shown in figure 1, overall group 147 
analysis indicated a significant difference between wild-type- and knockout-mice with 148 
respect to cartilage damage (P = 0.0006) and synovial hyperplasia (P = 0.0536). No 149 
specific effects within wild-type- or knoukout-mice of exercise were found, nor 150 
interaction between genotype and exercise. Sidak’s multiple comparison test indicated 151 
that the effect was determined by the difference in genotype in the exercise group (P < 152 
0.0001 for cartilage damage – 95% CI of the difference between the means (0.1820 to 153 
0.5820) and P = 0.0184 for synovial hyperplasia – 95% CI of the difference between the 154 
means (0.03661 to 0.4627)) (Figure 1). 155 
 156 
Microarrays: Differential expression in knee-joints upon forced exrecise 157 
To identify genes responsive to the forced running regime in mice, genome wide gene 158 
expression in knee-cartilage was studied by microarray. Gene expression was detected 159 
before and after the running regime in interaction with the genetic background (wild-type 160 
and Dio2-/--mice). Figure 2 shows a schematic overview of the study strategy.  161 
After quality control and normalization, 20872 of the 45281 probes of the BeadChip 162 
array were used for analyses. Microarrays on human articular cartilage samples showed 163 
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corresponding numbers for specific expression [26]. In order to detect all articular 164 
cartilage genes that are responsive to the applied running regime, we performed 165 
differential expression analyses in 3 strata: total (A), Dio2-/- (B) and wild type (C) group 166 
(Figure 2). For each strata significance was adjusted for multiple testing according to the 167 
“Benjamini and Hochberg” method. In the total and wild type strata, we independently 168 
detected respectively 1862 and 892 probes representing 1699 and 830 genes (558 169 
overlapping) that were significantly differentially expressed between the forced exercise 170 
and the control group. In contrast, in the Dio2-/--stratum, this comparison did not result in 171 
any significantly differentially expressed probes after multiple testing. Among the 172 
differentially expressed probes in the total and wild-type groups, we observed 173 
respectively 102 and 97 probes with a fold-change of 1.5 and higher that together 174 
consisted of 158 significant unique probes, representing 147 unique transcripts that were 175 
responsive to the running regime (Figure 2 and Supplement table S1). Notably, of the 176 
158 differentially expressed probes, 31 were up-regulated (20%) and 127 showed down-177 
regulation (80%). Among the 147 unique transcripts, we observed genes known for a 178 
potentially role in cartilage homeostasis and disease, such as Proteoglycan 4, also known 179 
as Lubricin (Prg4, 1.95-fold down; P=4.44 x 10-2)[27], myocyte enhancer factor 2C 180 
(Mef2c, 1.9-fold down; P=3.05 x 10-2)[28, 29] and connective tissue growth factor (Ctgf, 181 
also known as Ccn2, 1.79-fold down; P=1.32 x 10-2)[30]. 182 
Technical validation of our microarray results was carried out by RT-qPCR in the 183 
discovery cohort (20 samples previously included in the microarray analyses). Genes to 184 
be validated were selected based on P-value and fold difference (differential reaction on 185 
mechanical stress). Here, 19 out of the 20 genes tested showed similar effect sizes and 186 
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direction as the original data, only Pfn1 did not show similar effect of expression (see 187 
Supplementary table S2). 188 
 189 
Pathway analyses: Protein-protein interactions and gene enrichment analyses 190 
To identify functional connections between the genes that were found as differentially 191 
expressed (Table S1) we determined the protein-protein interaction prediction using 192 
STRING-db. Analyzing the 147 differentially expressed genes, representing 124 unique 193 
proteins, showed enrichment of interaction in the subset of proteins (P=1.61x10-4; 63 194 
interactions; Figure S1), indicating that the gene-products that were identified are closely 195 
interacting as a response to the forced running regime.  196 
Furthermore, we assessed whether the differentially expressed genes occurred more 197 
frequently in a specific pathways in mice. Gene enrichment analyses revealed enrichment 198 
for biological processes (GOTERM_BP_FAT) concerning, amongst others, “regulation 199 
of metabolic process” (P= 0.0063; GO: 0019222; N=46, e.g. Calr, Igfbp5, Sox4 and Tcf4), 200 
“skeletal system development” (P= 0.00395; GO:0001501; N=12, e.g. Ctnnb1, Ctgf, Sox4 201 
and Mef2c), “anatomical structure development” (P= 0.039; GO:0048856; N=36, e.g. 202 
Sox4, Notch3, Egfr, Ctnnb1 and Mef2c), and “regulation of response to stress” 203 
(P=0.0171; GO:0080134; N=14; Setd8, Ankrd1, Mef2c, Egfr and Ctgf) with application 204 
of a false discovery rate algorithm. 205 
To connect thyroid hormone signaling with the effects of forced mechanical stress, we 206 
added genes involved in intracellular thyroid hormone signaling (Dio2, Thra, Thrb and 207 
Rxra) into the protein-protein interaction prediction. The network that is formed (Figure 208 
3) shows thyroid signaling genes/proteins to be incorporated into the large network, as 209 
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previously seen (Figure S1). Thyroid signaling was found to interact directly with the 210 
differential expressed genes through, Ctgf (A) and Egfr (B), via thyroid receptor alpha 211 
(Thra) and retinoid x receptor (Rxra), both known factors in the development of OA[30-212 
32].  213 
 214 
Genes differentially expressed in Dio2-/- mice compared to wild type mice upon a 215 
forced running regime.  216 
Since we found differences in differential expression patterns between knockout and wild 217 
type mice upon the forced running regime, we assessed which of the 147 differentially 218 
expressed genes (Figure 1 and Supplementary Table S1) showed significant interaction 219 
between running regime and genetic background based on nominal P-values. In total 29 220 
probes, representing 29 genes were found be significantly different expressed in 221 
knockout-mice as compared to wild type-mice when undergoing a forced running regime 222 
(Table 1). The significant differences in effect (beta-values), as a result of the running 223 
regime, between the knockout- and the wildtype-group can be devided in 3 sub-groups. 224 
Each group shows a different effect-size based on “genotype” for the 29 genes found to 225 
show a significant interaction. We identified 4 genes that showed no differential 226 
expression upon running in wild-type mice, but are differentially expressed (down-227 
regulated) upon running in Dio2-/-  mice (Group 1; e.g. Gnas and Rhbdl2). In total 16 228 
genes only showed differential expression in wild-type mice and not in the Dio2-/- mice 229 
(Group 2; e.g. Hmgb2, Calr and Lbh) whereas, 9 genes showed significant differential 230 
effect-sizes between wild-type and knockout mice, but having the same direction of effect 231 
(Group 3; e.g. Sox4 and Socs2). Depending on the gene-expression pattern the genes in 232 
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the different groups could mark a favorable effect in the Dio2-knockout mice (Group 1) 233 
or an unfavorable effect in wild type cartilage homeostasis (Group 2). 234 
Tabel	  1:	  Genes	  that	  show	  significant	  differential	  expression	  upon	  the	  running	  regime	  
between	  wild-­‐type-­‐	  and	  knockout-­‐mice	  (interaction)	  
Run	  vs	  NoRun	  in	  	   Run	  vs	  NoRun	  in	  	  
	  	   Knockout	   Wildtype	   Interaction	  
Symbol	   Beta	   St.	  Error	   P-­‐value	   Beta	   St.	  Error	   P-­‐value	   P-­‐value	  
Group	  1:	  Genes	  with	  an	  effect	  of	  the	  running	  regime	  in	  knockout-­‐	  but	  not	  in	  wild-­‐type-­‐mice	  
Hist1h2an	   -­‐1,024	   0,2603	   0,000	   -­‐0,186	   0,1088	   0,087	   0,0030	  
Gnas	   -­‐0,956	   0,2318	   0,000	   -­‐0,258	   0,1473	   0,080	   0,0111	  
Rhbdl2	   -­‐1,135	   0,2176	   0,000	   -­‐0,349	   0,2638	   0,185	   0,0215	  
E130112E08Rik	   -­‐1,041	   0,2981	   0,000	   -­‐0,26	   0,2171	   0,231	   0,0343	  
Group	  2:	  Genes	  with	  an	  effect	  of	  the	  running	  regime	  in	  wild-­‐type-­‐	  but	  not	  in	  knockout-­‐mice	     
Anxa11	   0,02	   0,0852	   0,818	   -­‐0,636	   0,0668	   0,000	   0,0000	  
Setd8	   -­‐0,006	   0,0864	   0,943	   0,725	   0,1044	   0,000	   0,0000	  
Phdla1	   -­‐0,152	   0,1019	   0,136	   -­‐0,591	   0,1011	   0,000	   0,0022	  
Hmgb2	   0,131	   0,1439	   0,363	   0,666	   0,1476	   0,000	   0,0095	  
Calr	   -­‐0,086	   0,1561	   0,581	   -­‐0,664	   0,1658	   0,000	   0,0111	  
Gdi1	   0,313	   0,2297	   0,173	   0,923	   0,1446	   0,000	   0,0247	  
Lbh	   -­‐0,13	   0,0682	   0,057	   -­‐0,889	   0,0761	   0,000	   0,0000	  
Fmo5	   -­‐0,028	   0,1028	   0,784	   -­‐0,622	   0,0848	   0,000	   0,0000	  
Igsf4a	   -­‐0,171	   0,0978	   0,081	   -­‐0,789	   0,1221	   0,000	   0,0001	  
Fcho1	   0,132	   0,1144	   0,250	   0,665	   0,1106	   0,000	   0,0008	  
Serpinb1a	   0,396	   0,3687	   0,283	   -­‐0,877	   0,1145	   0,000	   0,0010	  
Mtpn	   -­‐0,082	   0,1084	   0,451	   -­‐0,594	   0,1121	   0,000	   0,0010	  
Rbm47	   -­‐0,09	   0,075	   0,229	   -­‐0,592	   0,1011	   0,000	   0,0013	  
LOC433464	   -­‐0,086	   0,1638	   0,599	   -­‐0,675	   0,0788	   0,000	   0,0015	  
Rer1	   -­‐0,185	   0,1714	   0,281	   -­‐0,611	   0,1121	   0,000	   0,0195	  
Hist1h4i	   0,113	   0,2763	   0,684	   -­‐0,811	   0,1011	   0,000	   0,0214	  
Group	  2:	  Genes	  with	  an	  effect	  of	  the	  running	  regime	  in	  both	  wild-­‐type-­‐	  and	  knockout-­‐mice	  
Mll5	   -­‐1,378	   0,2306	   0,000	   -­‐0,439	   0,1184	   0,000	   0,0003	  
Chd1	   -­‐1,178	   0,2311	   0,000	   -­‐0,307	   0,1125	   0,006	   0,0007	  
Septin11	   -­‐0,28	   0,0887	   0,002	   -­‐0,671	   0,0918	   0,000	   0,0022	  
Sox4	   -­‐0,479	   0,1399	   0,001	   -­‐0,969	   0,1064	   0,000	   0,0053	  
Gins1	   0,771	   0,305	   0,011	   1,596	   0,0735	   0,000	   0,0085	  
Socs2	   -­‐0,337	   0,1132	   0,003	   -­‐0,713	   0,0881	   0,000	   0,0088	  
C330023M02Rik	   -­‐0,308	   0,1498	   0,040	   -­‐0,678	   0,054	   0,000	   0,0202	  
Hgsnat	   -­‐0,29	   0,1274	   0,023	   -­‐0,621	   0,1001	   0,000	   0,0410	  
Rap2c	   -­‐0,385	   0,0743	   0,000	   -­‐0,628	   0,0955	   0,000	   0,0449	  
 235 
1The beta-value is representing the difference in fold change between the running group and the non-running group. 236 
The direction of the beta-value is how the running-group is different from the non-running group. 237 
 238 
2The standard error is showing the variation of the beta-value between samples. 239 
 240 
3The nominal P-value is the P-value of that the single probe that was calculated to tell whether based on this single 241 
probe, the expression levels between runners is different of that of non-runners. 242 
 243 
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4The Interaction P-value is a summarizing value that tells whether the difference caused by exercise is significantly 244 
different between the knockout- and the wild-type-stratum  245 
 246 
247 
  14 
DISCUSSION 247 
Dio2-deficient mice showed less cartilage damage and reduced severity of synovitis in a 248 
treadmill running model of OA. The absence of significant differential gene expression 249 
between the running and no-exercise group in Dio2-/- mice suggests that degenerative 250 
pathways are not activated in this knockout strain despite the biomechanical burden that 251 
is imposed. These data provide novel support for inhibition of DIO2 as a therapeutic 252 
strategy in OA, in particular since no striking developmental skeletal phenotype appears 253 
present in the Dio2-/- mice (results not shown). Upon forced mechanical loading, wild 254 
type mice showed clear signs of OA and differential expression of genes associated with 255 
the disease, supporting the use of forced running as an OA-model in mice. A subset of the 256 
genes was found directly interacting with thyroid signaling through Thra, Rxra and Dio2, 257 
depicted in Figure 3. This indicates the importance of thyroid hormone signaling as a 258 
regulatory system in the response to stress and, when suppressed, for the maintenance of 259 
cartilage homeostasis. 260 
With the differential expressed genes in the wild-type stratum and the combined 261 
knockout/wild-type stratum, pathway enrichment was found for expected biological 262 
processes, such as “skeletal system development”, but also for processes involved in 263 
“regulation of response to stress”. Notably, genes overlapping between these enriched 264 
processes as well as being ‘nodes’ in the recognized protein interaction networks (Egfr 265 
(B) and Ctnnb1(C); Figure 3) are well known for their association with OA [30, 33, 34]. 266 
These could, therefore, point at important modulators affecting the propensity to develop 267 
OA upon mechanical stress and as such at potential drugable targets for novel therapeutic 268 
approaches.  269 
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In contrast, when assessing gene expression in the knockout-group alone, we found no 270 
significant differential gene expression upon severe mechanical loading, after multiple 271 
testing adjustment. Taken together with the pathology observations these data indicate 272 
that the repression of Dio2 is beneficial against the development of cartilage damage 273 
upon mechanical stress. This effect could theoretically also be caused by a difference in 274 
power between the different strata (wild-type and knockout). However, since the 275 
comparison made in knockout animals (6 running versus 3 controls) is comparable to the 276 
wildtype animals (8 running versus 3 controls), this is unlikely to explain the complete 277 
absence of a significant differentially expressed gene in the knockout stratum.  278 
Looking at the effect of Dio2-deficiency on gene expression, we found that the gene 279 
expression response upon exercise between wild-type and knockout-mice was 280 
significantly different for 29 genes with nominal significance, of the total set of 147 281 
differentially expressed genes. Genes categorized in group 1 (Table 1), showing no 282 
differential expression upon forced running in wild-type mice, but are differentially 283 
expressed with nominal significance in Dio2-/- mice (E130112E08Rik, Gnas, Hist1h2an 284 
and Rhbdl2) could represent the respective favorable effects. Gnas, for example, is 285 
involved in skeletal development (GO:0001501) and complex skeletal disorders such as 286 
Albright Hereditary Osteodystrophy that can lead to early OA [35]. Gnas upregulation 287 
was found directly regulating hypertrophic differentiation of growth plate cartilage in 288 
vivo [36]. The knockout-specific down-regulation of Gnas upon forced running could be 289 
a protective mechanism within the Dio2 knockout mouse.  290 
We hypothesize that the sixteen genes within group 2, only showing differential 291 
expression in wild-type mice and not in the knockout-group (e.g. Hmgb2 and Calr), 292 
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represent the unfavorable, damaging effects of forced running in wild type mice. Hmgb2 293 
was shown to be expressed at higher levels in human MSCs as compared to human 294 
articular chondrocytes and the expression declined during chondrogenic differentiation of 295 
MSCs [37]. The up-regulation of Hmgb2 seen in wild type-mice upon forced running 296 
could be explained as a marker that changes in the differentiation status of the 297 
chondrocytes are occurring. A second interesting member of this group is calreticulin 298 
(Calr). Calr interacts with the glucocorticoid receptor (GR). It may also interact with 299 
other steroid receptors or thyroid receptors in a similar way [38]. Furthermore, Calr was 300 
shown to be involved in cartilage thinning of mandibular cartilage in a rat model that 301 
studied the effects of compressive mechanical loading [39]. In our forced running 302 
experiment we see a similar induction of Calr expression upon stress, but not in the Dio2 303 
knockout-mice, possibly giving the knockout-mouse an advantage against the formation 304 
of OA-like degradation or cartilage thinning. 305 
Nine additional genes showed significant differential effect-sizes between wild-type and 306 
knockout mice, albeit the same direction of effect (e.g. Sox4 and Socs2). Notable within 307 
this third group (Table 3) is Sox4, which was previously found to be expressed very early 308 
during chondrogenesis [40], much earlier than the well defined Sox5 and Sox6 [41]. 309 
Furthermore, it was shown that expression of Sox4 could be stimulated by adding 310 
physiological concentrations of human parathyroid hormone (PTH), indicating 311 
involvement of the PTH/PTHrP receptor [42]. Here we show that Sox4 expression is 312 
influenced by the absence of Dio2. In the knockout-mice the expression of Sox4 is 2 313 
times less down-regulated upon running when compared with the control group. How this 314 
  17 
influences the structural integrity of articular cartilage remains unknown. Other genes in 315 
the list have no straight-forward connection to OA based on current literature.  316 
In conclusion, in the current paper we find that Dio2 deficiency has a protective effect on 317 
the homeostasis of articular cartilage in the knee-joints of mice undergoing a forced 318 
running regime. This is consistent with our earlier findings, showing that 319 
pharmacological inhibition of deiodinases in a human in vitro chondrogenesis model has 320 
a beneficial effect on the early formation and maintenance of articular cartilage ECM [18]. 321 
It is therefore hypothesized that control of thyroid hormone signaling, both during 322 
development and adult cartilage maintenance, is essential to ensure normal bone and 323 
cartilage homeostasis, and that it could act as the master-switch that forces maturational 324 
arrested chondrocytes to re-activate the endochondral ossification process, leading to 325 
articular cartilage destruction. Our results show that interfering with intracellular thyroid 326 
hormone levels could be a powerful way to oppose the pathological events that are 327 
occurring in OA. 328 
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LEGENDS TO THE FIGURES: 474 
Figure 1.  475 
Histological scoring of osteoarthritis. Comparing wild-type and Dio2-/- mice as well as 476 
the effect of forced running. (A) Frontal Haematoxylin-Safranin O stained sections of 477 
C57Bl/6 wild-type and Dio2-/- knees (medial) of mice subjected to a running regime (run) 478 
and control mice (no run) (magnification 10x). (B) Cartilage damage was increased in 479 
wild-type mice as compared to Dio2-/- mice (2-way ANOVA p = 0.0006) and (C) a 480 
similar trend was observed for synovitis (2-way ANOVA p=0.0536). None of the other 481 
comparisons (e.g. ‘WT no run’ versus ‘KO no run’) were found significantly different. 482 
Data are shown as individual values, mean and 95% confidence intervals.  483 
 484 
Figure 2. 485 
Overview of the study strategy. Following microarray analysis, data were statistically 486 
analyzed. Secondary analyses using gene enrichment analysis and interaction analysis 487 
will lead to a set of genes which will be technically validated. 488 
 489 
Figure 3. 490 
Gene networks in search tool for the retrieval of interacting genes. Screenshot of the 491 
protein–protein interactions (STRING-db) for the 147 genes differing >1.5-fold between 492 
‘runners’ and controls, including thyroid signaling members; Dio2, Thra, Thrb and Rxra 493 
(encircled by the dashed line). Mayor hubs in the network are depicted by A) ctgf, B) egfr, 494 
and C) ctnnb1. Disconnected proteins are hidden. 495 
496 
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Figure 1 497 
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Figure 2 499 
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Figure 3501 
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MATERIALS AND METHODS 502 
Animal experiments 503 
Dio2-/- mice were a kind gift of Dr. V. Galton (Dartmouth Medical School, NH, USA)[1] 504 
and were backcrossed onto the C57Bl/6 background. In the experiments reported here, 505 
mice were in the 6th generation of backcrossing. C57Bl/6 mice are known to develop 506 
spontaneous OA [2] and this is enhanced by forced treadmill running with incline[3]. 507 
Wild-type C57/Bl6 mice were purchased from Janvier (Le Genest St Isle, France). All 508 
experiments were approved by the Ethics Committee for Animal Research (KU Leuven, 509 
Belgium). 510 
Four to 6 months old male Dio2-/- (n=22) and wild-type mice (n=30) were subjected to a 511 
forced-running exercise regimen on a four lane modular treadmill (Columbus Instruments, 512 
Columbus, OH, USA).  These mice ran for 3 weeks 1 hour/day, 5 days/week, at a speed 513 
of 11 m/min and with an inclination of 5°.  Dio2-/- (n=10) and wild-type (n=10)  mice 514 
were used as non-running controls. All animals were littermates and were caged together 515 
and housed in the same facility.  516 
 517 
Histological assessment of osteoarthritis 518 
At the end of the experiment, mice were sacrificed; right knees were processed for 519 
histology and left knees for gene expression analysis.  Right knees were fixed overnight 520 
at 4°C in 2% formaldehyde, decalcified for 3 weeks in 0.5M EDTA pH 7.5 and 521 
embedded in paraffin. Severity of disease was determined by histological scores on 522 
hematoxylin/eosin or Safranin O stained sections (5µm) throughout the knee (5 sections 523 
at 100µm distance). Both cartilage damage and synovial hyperplasia were assessed based 524 
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on OARSI guidelines [4, 5]. For cartilage damage, both depth of lesions (score 0-6) and 525 
extent of lesions (score 0-4) were evaluated in a combined score (depth x extent)[4]. 526 
Lesion grades represent the following features: 0 – surface and cartilage morphology 527 
intact; 1 – superficial zone fibrillation; 2 – surface discontinuity; 3 – vertical fissures; 4 – 528 
cartilage erosions; 5 – denudation of cartilage and exposure of subchondral bone; 6 529 
remodelling including microfracture and osseus repair above the previous surface. Extent 530 
scores represent: 0 – no lesions; 1 – less than 10%; 2 – 10 to 25%; 3 – 25 – 50%; 4 – over 531 
50%). Medial and lateral tibial and femoral cartilages were scored but lesions were only 532 
seen in the tibia. The score represents the sum of medial and lateral scores. For synovial 533 
hyperplasia, severity was determined on a 0-3 scale[5]. Scoring was done by 2 534 
independent readers, blinded to the genotype. 535 
For gene expression studies, cartilage was micro-dissected and separately stored, snap 536 
frozen in liquid nitrogen, at minus 80 degrees upon isolation.  537 
 538 
RNA isolation 539 
To gain isolation efficiency and thereby mRNA quality, the articular cartilage material of 540 
the knee-joints of two mice were pooled. The samples were subsequently pulverized 541 
using a Retsch MM200 apparatus under cryogenic conditions. After one run (20 seconds 542 
at 20 Hz), 1 ml of Trizol reagent (Life Technologies, Bleiswijk, The Netherlands) was 543 
added to the milling-chamber containing the pulverized joint. The joint-tissue and Trizol 544 
were mixed vigorously by performing a second run (20 seconds at 20 Hz). The frozen 545 
joint/Trizol mixture was scraped out of the milling-chamber and was then left to thaw. 546 
After addition of 200 µl of chloroform the sample was mixed and centrifuged for 15 547 
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minutes at 14.000g. The clear aqueous layer was transferred to a new vial and 1 volume 548 
of 70% ethanol/DEPC-treated water was added to precipitate RNA. The RNA was 549 
isolated and washed using the RNeasy mini kit (Qiagen, Venlo, The Netherlands) 550 
according to the manufacturer’s protocol. RNA quality was assessed using a Biocore lab-551 
on-a-chip and quantity was assessed using a Nanodrop spectrophotometer. RIN values 552 
above 7 were considered of sufficient quality for further processing. 553 
 554 
Mouse experiment analysis 555 
All analyses were performed with GraphPad Prism. We hypothesized that the dependent 556 
variables (cartilage damage and synovial hyperplasia) could be determined by two 557 
independent variables (genotype and exercise) and therefore tested the effect of genotype, 558 
exercise and their interaction using 2-way ANOVA. The assumptions underlying the 559 
ANOVA were assessed: the dependent variables were measured at a ratio level and the 560 
independent variables were categorical, independent and based on independent 561 
observations. For synovial hyperplasia, data were normally distributed based on visual 562 
analysis and the D’Agostino – Pearson omnibus normality test.  4-group suggested 563 
homogeneity of variance for both datasets based on the Brown-Forsythe test. For 564 
cartilage damage analysis, data were not normally distributed and there was no 565 
homogeneity of variance. We therefore performed a log transformation of the scores 566 
resulting in positive assessment of the normal distribution and homogeneity of variance 567 
assessed as above. 2-way ANOVA and post-hoc Sidak test taking into account multiple 568 
comparisons were applied. Data are presented as mean + 95% CI and p-values < 0.05 569 
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were considered significant. In the post-hoc tests, adjusted p-values < 0.05 correspond 570 
with 95% CI for differences between means that do not contain the zero value. 571 
 572 
Microarray analysis 573 
For first- and second-strand reverse transcription, 500 ng of total RNA was used as 574 
template. Complementary DNA synthesis, amplification, biotin labeling and 575 
hybridization onto the microarrays was performed using the Ambion TotalPrep-96 RNA 576 
amplification kit (Life Technologies, Bleiswijk, The Netherlands) according to 577 
manufacturer’s protocol. Samples were dispersed for experimental condition over the 578 
arrays of 6 chips from a single batch, and each chip contained a replicate sample that was 579 
also present on a second chip, to exclude batch effects across chips. After hybridization 580 
on Illumina MouseWG-6 v2 BeadChip microarrays (Illumina, Eindhoven, The 581 
Netherlands) the slides were scanned with the Illumina Beadscanner 500GX and after 582 
basic quality control (QC) using Beadstudio software the intensity values were 583 
normalized using the “rsn” option in the Lumi R-package. All samples were included in 584 
the dataset. Replicates measured over the different chips were taken into account when 585 
performing normalization. For further analysis, the replicate with the lowest number of 586 
calls was discarded from the dataset.  587 
The raw probe-level data were exported for analyses using the Limma R-package. We 588 
checked the data for large-scale batch effects between chips using a principal component 589 
analysis. After correction for multiple testing as implemented in the “BH” (Benjamini 590 
and Holm) option on Limma, we listed the significantly differentially expressed probes 591 
between running and control mice (challenge), correcting for genotype, and for knockout 592 
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and Dio2-/- separately.  The genes were then further filtered with a cut-off fold-difference 593 
≥ 1.5. 594 
Using SPSS (Release 20.0.0, IBM) we used the ‘Generalized Estimation Equation’ 595 
(GEE) option to investigate the influence of genotype on the significantly differentially 596 
expressed probes between running and control mice thereby calculating the interaction-597 
term. 598 
 599 
Pathway analysis and protein-protein interaction networks 600 
Gene enrichment among the genes with significant differential expression was performed 601 
with STRING (Search Tool for the Retrieval of Interacting Genes/Proteins 9.1) [6]. The 602 
probe-list as stated in table S1 was entered into the indicated box to search for multiple 603 
protein-protein interactions in mus musculus. Alternative names, provided by the 604 
STRING program, given for ‘LOC’ and ‘Riken’ annotated genes were accepted as input 605 
for the interaction prediction. Selecting for biological processes identified in the Gene 606 
Ontology database (GOTERM_BP_FAT in the options menu implemented in STRING) 607 
and using the genome background (mus musculus). Pathways with P-val ≤0.05 after FDR 608 
correction for multiple testing were considered significant. Enrichment in protein-protein 609 
interactions was also analyzed using the STRING database. Genes were classified as 610 
network ‘nodes’ when having 10 or more interactions. 611 
 612 
Quantitative RT-PCR assays (validation) 613 
Validation of the micrarray results was performed by quantitative real-time PCR. 500 ng 614 
of total RNA was processed with the First Strand cDNA Synthesis Kit according to the 615 
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manufacturer’s protocol (Roche Applied Science, Almere, The Netherlands) upon which 616 
cDNA was diluted 5 times. RT-qPCR measurements were performed on the Roche 617 
Lightcycler 480 II, using Fast Start Sybr Green Master reaction mix according to the 618 
manufacturer’s protocol (Roche Applied Science). Relative gene expressions of the 619 
Roche Lightcycler 480 II data were calculated by using the 2-∆∆Ct method, in which Ct 620 
indicates cycle threshold, the fractional cycle number where the fluorescent signal 621 
reaches detection threshold.[7] Primer efficiencies were verified in advance; by 622 
performing a concentration curve experiment (primer sequences used are listed in Table 623 
S3). Only primers showing a perfect correlation between Ct-value and concentration and 624 
with a single peak in the melting-curve calculation (Lightcycler480 SW 1.5 software) 625 
were used. By selecting 20 genes covering the broad range of p-values and fold-changes 626 
as found with the microarray analyses we wanted to demonstrate the reliability of the 627 
microarray technique. The glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 628 
household gene expression was used as internal standard for RNA quantity.[8, 9]  629 
 630 
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SUPPLEMENTAL INFORMATION 667 
 668 
Supplemental Figure Legends: 669 
Figure S1: Study design. Graphical representation of the study design. 670 
 671 
Figure S2: Gene networks in search tool for the retrieval of interacting genes 672 
(STRING). Screenshot of the protein–protein interactions determined with STRING-db 673 
for the 147 genes differing at least 1.5-fold between challenged and unchallenged mice 674 
(disconnected proteins are hidden). 675 
 676 
677 
  40 
Supplemental Figures:  677 
Figure S1. 678 
 679 
Figure S2. 680 
 681 
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Supplementary Table Legends: 682 
 683 
Table S1: Overall differential expressed probes (N=158) upon exercise. 684 
Table S2: Technical validation by RT-qPCR. 685 
Table S3: RT-qPCR primer sequences. 686 
 687 
688 
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Supplemental Tables: 688 
Table S1: 689 
Table S1: Differential expressed probes (N=158)  
OVERALL DIFFERENTIAL EXPRESSED 
PROBES     
SYMBOL adj.P.Val 
Abs 
FC 
Gins1 3,77E-03 2,30 
Purb 3,77E-03 -1,84 
Apip 4,72E-03 1,51 
Polr1d 4,72E-03 1,50 
Rasa1 5,20E-03 -1,87 
Ccnd2 6,52E-03 -1,97 
Ccnd2 6,71E-03 -1,82 
Sox4 6,93E-03 -1,66 
Srr 7,55E-03 -1,90 
mt-Co2 8,00E-03 -3,68 
Dusp7 8,30E-03 -1,51 
Rps27a 9,84E-03 1,56 
Mll5 9,84E-03 -1,85 
Hbb-b1 1,12E-02 -1,88 
Mllt4 1,15E-02 -1,88 
Bcl6 1,16E-02 -1,53 
4933407C03Rik 1,23E-02 -1,55 
Prf1 1,23E-02 -1,80 
Srr 1,23E-02 -2,05 
LOC665281 1,23E-02 -1,87 
Ppp1r12a 1,25E-02 -1,54 
LOC676974 1,26E-02 1,52 
Tcf4 1,27E-02 -1,53 
Naca 1,27E-02 1,50 
LOC100047419 1,31E-02 -1,52 
Csda 1,31E-02 -1,61 
A230057M07Rik 1,32E-02 -1,79 
Ctgf 1,32E-02 -1,79 
Ankrd11 1,33E-02 -1,50 
Rbm5 1,39E-02 -1,53 
mt-Nd1 1,41E-02 -2,62 
9030024J15Rik 1,50E-02 -1,67 
LOC671878 1,53E-02 -1,50 
Cnot4 1,54E-02 -1,67 
Ube2l6 1,59E-02 1,68 
LOC386021 1,59E-02 -1,57 
Ide 1,61E-02 -1,51 
B430305P08Rik 1,63E-02 -1,65 
Pptc7 1,65E-02 -1,65 
LOC100046770 1,69E-02 1,67 
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Chka 1,69E-02 -1,76 
Gdi1 1,71E-02 1,55 
Igfbp5 1,71E-02 -1,63 
LOC386078 1,75E-02 -1,64 
Rhbdl2 1,86E-02 -1,65 
LOC385825 1,87E-02 -1,62 
Ybx3 1,88E-02 -1,50 
LOC386218 1,89E-02 -1,60 
Ctgf 2,10E-02 -1,68 
BC030476 2,14E-02 -2,14 
Nfic 2,19E-02 -1,80 
4732462B05Rik 2,21E-02 -1,57 
LOC671641 2,29E-02 -1,84 
Marveld1 2,34E-02 -1,53 
mtDNA_COXII 2,53E-02 -2,10 
Ankhd1 2,64E-02 -1,57 
Igk-V33 2,72E-02 2,40 
LOC546015 2,81E-02 -1,71 
Fam134b 2,83E-02 -1,56 
Cdo1 2,87E-02 -1,63 
Ankrd1 2,95E-02 -1,65 
Tde2 3,00E-02 -1,58 
Mef2c 3,05E-02 -1,90 
Hspa8 3,08E-02 1,55 
Bach2 3,11E-02 -1,58 
Col1a2 3,11E-02 -1,75 
Hsp90b1 3,12E-02 -1,55 
Htra4 3,12E-02 -1,84 
IGHV1S119_L33961_Ig_heavy_variable_1S119_14 3,12E-02 1,78 
Ddx21 3,14E-02 -2,00 
Myh4 3,21E-02 -2,26 
LOC674195 3,30E-02 -1,58 
3300001P08Rik 3,31E-02 -1,78 
B230387C07Rik 3,34E-02 -1,97 
Chd1 3,38E-02 -1,65 
Nfib 3,46E-02 -1,53 
E130112E08Rik 3,46E-02 -1,55 
Pfn1 3,52E-02 1,67 
Gnas 3,54E-02 -1,51 
Golga2 3,61E-02 -1,84 
Cox6c 3,61E-02 -1,90 
Mef2c 3,88E-02 -1,79 
Zxda 4,07E-02 -1,53 
Fbln2 4,07E-02 -1,57 
mtDNA_ND4L 4,15E-02 -1,62 
Amotl1 4,21E-02 -1,57 
Tnxb 4,35E-02 -1,54 
Zeb2 4,44E-02 -1,51 
Phospho1 4,44E-02 -1,57 
Prg4 4,44E-02 -1,95 
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Usp48 4,47E-02 -1,56 
Stfa1 4,53E-02 1,80 
Ermap 4,53E-02 -1,58 
S3-12 4,61E-02 -1,52 
Tcrb-V8.2 4,66E-02 1,51 
LOC383077 4,69E-02 -1,53 
LOC270589 4,69E-02 -1,60 
2610024B07Rik 4,84E-02 -1,62 
2010321I05Rik 4,85E-02 -1,52 
Ctnnb1 4,90E-02 -1,51 
Nktr 4,98E-02 -1,59 
Hist1h2an 5,00E-02 -1,50 
   
WILD-TYPE SPECIFIC PROBES     
SYMBOL adj.P.Val FC 
4930572J05Rik 2,87E-04 -1,56 
Cd300lg 4,54E-04 -1,55 
C330023M02Rik 1,22E-03 -1,60 
Anxa11 1,22E-03 -1,55 
LOC433464 1,58E-03 -1,60 
Notch3 1,95E-03 -1,54 
Myo6 4,33E-03 -1,55 
Klf7 4,33E-03 -1,53 
Lbh 4,44E-03 -1,85 
Nrp1 4,89E-03 -1,52 
2210023G05Rik 5,23E-03 -1,54 
Socs2 5,60E-03 -1,64 
Birc5 6,64E-03 1,54 
Pja2 6,70E-03 -1,58 
Chi3l3 6,70E-03 1,86 
Fmo5 6,91E-03 -1,54 
2400001E08Rik 7,00E-03 1,56 
Rer1 8,57E-03 -1,53 
scl0002617.1_582 8,75E-03 -1,52 
EG433016 8,84E-03 1,90 
Helb 9,77E-03 -1,54 
Fcho1 1,00E-02 1,59 
Setd8 1,05E-02 1,65 
Hgsnat 1,06E-02 -1,54 
Gadd45a 1,46E-02 -1,51 
100041294 1,50E-02 1,53 
Ube2g1 1,51E-02 -1,53 
Sept11 1,59E-02 -1,59 
Serpinb1a 1,62E-02 -1,84 
Igsf4a 2,01E-02 -1,73 
Hp 2,04E-02 1,78 
Hp 2,29E-02 1,82 
LOC669053 2,29E-02 2,74 
Fstl1 2,31E-02 -1,60 
Csrp3 2,47E-02 -1,68 
  45 
Col6a3 2,52E-02 -1,68 
Pja2 2,55E-02 -1,52 
Hmgb2 2,66E-02 1,59 
LOC380691 2,83E-02 1,58 
Tspo 2,87E-02 1,54 
Fhl1 3,09E-02 -1,52 
Mtpn 3,12E-02 -1,51 
Phlda1 3,20E-02 -1,51 
Rbm47 3,23E-02 -1,51 
Akp2 3,35E-02 -1,53 
E030026I10Rik 3,47E-02 -1,53 
Rap2c 3,53E-02 -1,55 
Pdgfra 4,08E-02 -1,50 
D16Ertd472e 4,11E-02 -1,56 
Calr 4,18E-02 -1,58 
Hist1h4i 4,19E-02 1,75 
Eif4a2 4,31E-02 -1,54 
Pcp2 4,44E-02 1,60 
Pgk1 4,76E-02 -1,61 
Tspo 4,88E-02 1,51 
Bat2 4,97E-02 -1,51 
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Table S2 692 
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Table S2: Technical validation by RT-qPCR 
 Microarray   RT-qPCR 
  FC adj. P-val FC 
Sox4 -1,66 6,93E-03 -1,62 
Srr -1,90 7,55E-03 -1,35 
Mll5 -1,85 9,84E-03 -1,13 
Mllt4 -1,88 1,15E-02 -1,53 
Bcl6 -1,53 1,16E-02 -1,06 
Tcf4 -1,53 1,27E-02 -1,24 
Ctgf -1,79 1,32E-02 -1,62 
Rbm5 -1,53 1,39E-02 -1,56 
9030024J15Rik 
(Egfr) -1,67 1,50E-02 -1,83 
Igfbp5 -1,63 1,71E-02 -1,59 
Col1a2 -1,75 3,11E-02 -1,46 
Pfn1 1,67 3,52E-02 1,00 
Gnas -1,51 3,54E-02 -1,10 
Fbln2 -1,57 4,07E-02 -1,90 
Tnxb -1,54 4,35E-02 -2,13 
Prg4 -1,95 4,44E-02 -2,30 
Ctnnb1 -1,51 4,90E-02 -1,09 
Nktr -1,59 4,98E-02 -1,58 
Col6a3 -1,68 2,52E-02 -1,85 
Calr -1,58 4,18E-02 -1,14 
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Table S3: 695 
Table S3: RT-qPCR primer sequences 
GAPDH Forward 5'-TGCCATGTAGACCCCTTGAAG-3' 
 Reverse 5'-ATGGTACATGACAAGGTGCGG-3' 
Sox4 Forward 5'-AAAGAAGGCTCTGGGGTGAT-3' 
 Reverse 5'-ATGCTCCCCTAAGCTCAACA-3' 
Srr Forward 5'-GTGCTGTCTCAGCATTTCCA-3' 
 Reverse 5'-CACCCAGTTCAGGGAGGTTA-3' 
Mll5 Forward 5'-AAGGCCTCTGCGCATAACTA-3' 
 Reverse 5'-ACATGGGGGCTGTAAGTGAG-3' 
Mllt4 Forward 5'-ACCTGGAGCTGTTCAGGAGA-3' 
 Reverse 5'-AGGACACCCTGTCACTGTCC-3' 
Bcl6 Forward 5'-CCTGAGGGAAGGCAATATCA-3' 
 Reverse 5'-TTCACGGGGAGGTTTAAGTG-3' 
Tcf4 Forward 5'-CGAATCACATGGGACAGATG-3' 
 Reverse 5'-AAACGGGGTTAAGGAGCAGT-3' 
Ctgf Forward 5'-CACTCTGCCAGTGGAGTTCA-3' 
 Reverse 5'-GTAATGGCAGGCACAGGTCT-3' 
Rbm5 Forward 5'-GGGGACAATGGGCTTTTTAT-3' 
 Reverse 5'-CCCAGGAAGTAGGGACACAA-3' 
9030024J15Rik (Egfr) Forward 5'-ACACTGCTGGTGTTGCTGAC-3' 
 Reverse 5'-TGCCTTGGCAGACTTTCTTT-3' 
Igfbp5 Forward 5'-GACCCCGGAAATGTATTCCT-3' 
 Reverse 5'-CCAACGCTTTGCTTTCTTTC-3' 
Col1a2 Forward 5'-GTGTTCAAGGTGGCAAAGGT-3' 
 Reverse 5'-GACCGAATTCACCAGGAAGA-3' 
Pfn1 Forward 5'-GCAAGACGGGGAATTTACAA-3' 
 Reverse 5'-GGACTAGCGTCTTGGCAGTC-3' 
Gnas Forward 5'-TTTTTCCCCCAGTGATTCTG-3' 
 Reverse 5'-AGGGAACTTTTGTGGCCTTT-3' 
Fbln2 Forward 5'-GGCCAGTCCTACTTTGTGGA-3' 
 Reverse 5'-TTCAATGCAGTTGGGTGGTA-3' 
Tnxb Forward 5'-AGCCTAACACAGGCTGGAGA-3' 
 Reverse 5'-CATGGTAGCCCTCAAGGTGT-3' 
Prg4 Forward 5'-AGAACCATGGGGTGGAAAAT-3' 
 Reverse 5'-CAAGACAACAGGAAGCAGCA-3' 
Ctnnb1 Forward 5'-ACCTTTCAGATGCAGCGACT-3' 
 Reverse 5'-TATCATCGGAACCCAGAAGC-3' 
Nktr Forward 5'-TGCCTGCTATCACTGTGGAG-3' 
 Reverse 5'-TCCTTTGATTTTCCGTCCAG-3' 
Col6a3 Forward 5'-GATCGTTCGCAGACTCAACA-3' 
 Reverse 5'-CTAAACTGCACGACCCCAAT-3' 
Calr Forward 5'-GAATACAAGGGCGAGTGGAA-3' 
  Reverse 5'-GGGGGAGTATTCAGGGTTGT-3' 
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